These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15336345)

  • 1. Development of a robust procedure for assessing powder flow using a commercial avalanche testing instrument.
    Hancock BC; Vukovinsky KE; Brolley B; Grimsey I; Hedden D; Olsofsky A; Doherty RA
    J Pharm Biomed Anal; 2004 Sep; 35(5):979-90. PubMed ID: 15336345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flowability characterisation of drug-excipient blends using a novel powder avalanching method.
    Nalluri VR; Kuentz M
    Eur J Pharm Biopharm; 2010 Feb; 74(2):388-96. PubMed ID: 19796683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohesive, multicomponent, dense powder flow characterization by NIR.
    Benedetti C; Abatzoglou N; Simard JS; McDermott L; Léonard G; Cartilier L
    Int J Pharm; 2007 May; 336(2):292-301. PubMed ID: 17240094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Powder specific active dispersion for generation of pharmaceutical aerosols.
    Crowder T; Hickey A
    Int J Pharm; 2006 Dec; 327(1-2):65-72. PubMed ID: 16930884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetrometry and estimation of the flow rate of powder excipients.
    Zatloukal Z; Sklubalová Z
    Pharmazie; 2007 Mar; 62(3):185-9. PubMed ID: 17416194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Packing properties of starch-based powders under mild mechanical stress.
    Zanardi I; Gabbrielli A; Travagli V
    Pharmazie; 2009 Jul; 64(7):440-4. PubMed ID: 19694180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a dual approach to assess powder flow from avalanching behavior.
    Lee YS; Poynter R; Podczeck F; Newton JM
    AAPS PharmSciTech; 2000 Jul; 1(3):E21. PubMed ID: 14727907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental observations of dry powder inhaler dose fluidisation.
    Tuley R; Shrimpton J; Jones MD; Price R; Palmer M; Prime D
    Int J Pharm; 2008 Jun; 358(1-2):238-47. PubMed ID: 18457930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between drained angle and flow rate of size fractions of powder excipients.
    Sklubalová Z; Zatloukal Z
    Pharmazie; 2009 Dec; 64(12):846-7. PubMed ID: 20095146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precipitated silica as flow regulator.
    Müller AK; Ruppel J; Drexel CP; Zimmermann I
    Eur J Pharm Sci; 2008 Aug; 34(4-5):303-8. PubMed ID: 18595668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization.
    Ye G; Wang S; Heng PW; Chen L; Wang C
    Int J Pharm; 2007 Jun; 337(1-2):80-7. PubMed ID: 17241757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared spectroscopic method for real-time monitoring of pharmaceutical powders during voiding.
    Barajas MJ; Cassiani AR; Vargas W; Conde C; Ropero J; Figueroa J; Romañach RJ
    Appl Spectrosc; 2007 May; 61(5):490-6. PubMed ID: 17555618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow rate and flow equation of pharmaceutical free-flowable powder excipients.
    Sklubalová Z; Zatloukal Z
    Pharm Dev Technol; 2013 Feb; 18(1):106-11. PubMed ID: 22149908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near InfraRed Spectroscopy homogeneity evaluation of complex powder blends in a small-scale pharmaceutical preformulation process, a real-life application.
    Storme-Paris I; Clarot I; Esposito S; Chaumeil JC; Nicolas A; Brion F; Rieutord A; Chaminade P
    Eur J Pharm Biopharm; 2009 May; 72(1):189-98. PubMed ID: 19059338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the Methods to Measure Powder Flow.
    Tan G; Morton DA; Larson I
    Curr Pharm Des; 2015; 21(40):5751-65. PubMed ID: 26446467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-state compatibility studies using a high-throughput and automated forced degradation system.
    Wakasawa T; Sano K; Hirakura Y; Toyo'oka T; Kitamura S
    Int J Pharm; 2008 May; 355(1-2):164-73. PubMed ID: 18215480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward better understanding of powder avalanching and shear cell parameters of drug-excipient blends to design minimal weight variability into pharmaceutical capsules.
    Nalluri VR; Puchkov M; Kuentz M
    Int J Pharm; 2013 Feb; 442(1-2):49-56. PubMed ID: 22917747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New methods characterizing avalanche behavior to determine powder flow.
    Lavoie F; Cartilier L; Thibert R
    Pharm Res; 2002 Jun; 19(6):887-93. PubMed ID: 12134962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.